AWG
LIMNW

Alpha Wave Global’s Liminatus Pharma Warrants LIMNW Stock Holding History

Alpha Wave Global’s Portfolio LIMNW Stock Details LIMNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-89,098
Closed -$10.7K – 32
2025
Q3 		$10.7K Hold
89,098
– – ﹤0.01% 26
2025
Q2 		$21.6K Buy
+89,098
New +$17.5K ﹤0.01% 31

Other funds holding LIMNW

CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Alpha Wave Global's LIMNW Position: Q4 2025 in Review

Alpha Wave Global sold out of Liminatus Pharma Warrants (LIMNW) in Q4 2025, closing a stake of 89,098 shares — an estimated $10.7K sold.

Alpha Wave Global first reported a position in LIMNW in Q2 2025 and held it in 2 quarters. The position peaked at $21.6K in Q2 2025. 24 funds tracked by Wall St. Rank hold LIMNW as of Q4 2025.

  • Alpha Wave Global reported no remaining Liminatus Pharma Warrants position as of Q4 2025 after selling out during the quarter.
  • Alpha Wave Global sold 89,098 Liminatus Pharma Warrants shares in Q4 2025, an estimated $10.7K.
  • Alpha Wave Global first reported a position in Liminatus Pharma Warrants in Q2 2025 and held it in 2 quarters.
  • Alpha Wave Global's Liminatus Pharma Warrants position peaked at $21.6K in Q2 2025.
  • 24 funds tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q4 2025.

Based on Alpha Wave Global's 13F filing for Q4 2025, filed 13 Feb 2026.